Wilmington, Delaware, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Global Metastatic Colorectal Cancer Therapeutics Market is estimated at a market value of US$ 5.9 billion in 2023 and is predicted to rise at a substantial CAGR of 4.2% during the forecast period of 2023 and 2030, according to RationalStat analysis.
Market Definition, Market Scope, and Report Overview
The numerous treatments and therapies used to manage colorectal cancer that have spread (metastasized) to other sections of the body are referred to as metastatic colorectal cancer (mCRC) therapy. Colorectal cancer develops in the colon or rectum and can spread to distant organs such as the liver or lungs, making treatment more difficult.
A combination of factors, including high incidence rates, advancements in medical research and diagnostics, targeted therapies, immunotherapies, combination approaches, healthcare investments, and increased awareness efforts, are driving the global market for metastatic colorectal cancer therapeutics.
- According to a deep-dive market assessment by RationalStat, the global metastatic colorectal cancer therapeutics market has been analyzed on the basis of market segments, including therapy, cancer type, distribution channel and geography/regions (including North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa, and Asia Pacific). The report also offers global and regional market sizing for the historical period of 2019-2022 and the forecast period of 2023-2030.
- Market intelligence for the global metastatic colorectal cancer therapeutics market covers market sizes on the basis of market value (US$/EUR Million) and volume (Units/Patients) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.
- In addition, the long-term sector and products/services 10-year outlook and its implications on the global metastatic colorectal cancer therapeutics market. It also includes the industry's current state – Production Levels, Capacity Utilization, Tech quotient, etc. Key information will be manufacturing capacity by country, installed base, import volumes, market size, key players, market size, dynamics, market data, insights, etc.
Request A Customization- https://store.rationalstat.com/store/global-metastatic-colorectal-cancer-therapeutics-market/#tab-ux_global_tab
Global Metastatic Colorectal Cancer Therapeutics Market: Segmental and Market Share Analysis
- On the basis of therapy, the targeted therapy segment is predicted to dominate the global metastatic colorectal cancer therapeutics market. This is due to their status as effective and sophisticated treatments as well as crucial life-sustaining functions.
- On the basis of cancer type, colorectal adenocarcinoma segment is anticipated to grow at a faster CAGR. Because large proportion of patients suffering from this type of cancer across the world.
Report Synopsis
| Report Metrics | Details |
| Base Year | 2023 |
| Forecast Period | 2023-2030 |
| Base Year Market Size | US$ 5.9 billion |
| Market Size Forecast | US$ 8.7 billion |
| Growth Rate | 4.2% |
| Key Market Drivers |
|
| Companies Profiled |
|
Explore more about this report- https://store.rationalstat.com/store/global-metastatic-colorectal-cancer-therapeutics-market/#tab-ux_global_tab
Competition Analysis and Market Structure
Prominent companies and leading players adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers & acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. Some of the key developments in the global metastatic colorectal cancer therapeutics market include,
- In January 2023, Akeda of Japan formed a cooperation with Hutchmed of Hong Kong to obtain marketing rights for the colorectal cancer medicine fruquintinib outside of China.
Some of the prominent players and suppliers operating and contributing significantly to the global metastatic colorectal cancer therapeutics market growth include Amgen Inc., Pfizer Inc., Novartis AG, Sanofi S.A., Genentech Inc., Eli Lilly and Company, Hoffmann-La Roche Ltd., Merck KGaA, Bristol-Myers Squibb Company, Roche Holding AG, Genentech Inc., Chia Tai Tianqing Pharmaceutical Group Co. Ltd, and Cardinal Health, among others.
Get A Free Sample- https://store.rationalstat.com/store/global-metastatic-colorectal-cancer-therapeutics-market/#tab-ux_global_tab
RationalStat has segmented the global metastatic colorectal cancer therapeutics market based on therapy, cancer type, distribution channel and region
- Global Metastatic Colorectal Cancer Therapeutics Market Value (US$ Million), Volume (Units/Patients), and Market Share (2019-2030) Analysis by Therapy
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Others
- Global Metastatic Colorectal Cancer Therapeutics Market Value (US$ Million), Volume (Units/Patients), and Market Share (2019-2030) Analysis by Cancer Type
- Colorectal Adenocarcinoma
- Gastrointestinal Carcinoid Tumors
- Global Metastatic Colorectal Cancer Therapeutics Market Value (US$ Million), Volume (Units/Patients), and Market Share (2019-2030) Analysis by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Metastatic Colorectal Cancer Therapeutics Market Value (US$ Million), Volume (Units/Patients), and Market Share (2019-2030) Analysis by Region
- North America Metastatic Colorectal Cancer Therapeutics Market
- US
- Canada
- Latin America Metastatic Colorectal Cancer Therapeutics Market
- Brazil
- Mexico
- Rest of Latin America
- Western Europe Metastatic Colorectal Cancer Therapeutics Market
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe Metastatic Colorectal Cancer Therapeutics Market
- Russia
- Poland
- Hungary
- Other CIS Countries
- Rest of Eastern Europe
- Asia Pacific Metastatic Colorectal Cancer Therapeutics Market
- China
- Japan
- India
- South Korea
- Australia
- ASEAN
- Indonesia
- Thailand
- Philippines
- Vietnam
- Malaysia
- Rest of ASEAN
- Rest of Asia Pacific
- Middle East & Africa Metastatic Colorectal Cancer Therapeutics Market
- GCC
- Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Rest of the GCC
- South Africa
- Nigeria
- Turkey
- Rest of the Middle East & Africa
- GCC
- North America Metastatic Colorectal Cancer Therapeutics Market
For more information about this report- https://store.rationalstat.com/store/global-metastatic-colorectal-cancer-therapeutics-market/#tab-ux_global_tab
Key Questions Answered in the Metastatic Colorectal Cancer Therapeutics Report:
- What will be the market value of the global metastatic colorectal cancer therapeutics market by 2030?
- What is the market size of the global metastatic colorectal cancer therapeutics market?
- What are the market drivers of the global metastatic colorectal cancer therapeutics market?
- What are the key trends in the global metastatic colorectal cancer therapeutics market?
- Which is the leading region in the global metastatic colorectal cancer therapeutics market?
- What are the major companies operating in the global metastatic colorectal cancer therapeutics market?
- What are the market shares by key segments in the global metastatic colorectal cancer therapeutics market?
Running a year End discount of 20% - https://store.rationalstat.com/store/global-metastatic-colorectal-cancer-therapeutics-market/#tab-ux_global_tab
Explore Our Trending Reports
- Global Swab Market- Global Swab Market is expected to grow at a CAGR of 6.6% over the forecast period of 2022-2028.
- Global Pet CBD (cannabidiol) Market- Global Pet CBD (cannabidiol) Market is expected to grow at a CAGR of 12.0% over the forecast period of 2022-2028.
- Global Medical Rehabilitation Service Market - Global Medical Rehabilitation Service Market is expected to grow at a CAGR of 6.1% over the forecast period of 2022-2028.
- Global Hepatitis B Virus Market- Global Hepatitis B Virus Market is expected to grow at a CAGR of 5.8% over the forecast period of 2022-2028.
- Global Hepatitis B Vaccine (Recombinant) Market- Global Hepatitis B Vaccine (Recombinant) Market is expected to grow at a CAGR of 5.6% over the forecast period of 2022-2028.
- Global Benign Prostatic Hyperpl Medication - Global Benign Prostatic Hyperpl Medication Market is expected to grow at a CAGR of 5.0% over the forecast period of 2022-2028.
- Global Red Light Therapy Device Market-Global Red Light Therapy Device Market is expected to grow at a significant CAGR of 4.2% over the forecast period of 2022-2028.
- US Pharmacy Market- US pharmacy market is anticipated to attain a value of US$ 706 million by 2030, growing at a compound annual growth rate (CAGR) of 3.9% during the forecast period.
- Global Retinoblastoma Treatment Market- global retinoblastoma treatment market is anticipated to attain a value of US$ 3.0 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period.
- Global Pet Relaxants Market- Global pet relaxants market is anticipated to attain a value of US$ 443 million by 2030, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
- Global Atopic Dermatitis Market-Global atopic dermatitis market is anticipated to attain a value of US$ 19.1 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.7% during the forecast period.
- Global Metastatic Colorectal Cancer Therapeutics Market- Global metastatic colorectal cancer therapeutics market is anticipated to attain a value of US$ 7.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.2% during the forecast period.
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Download Key Insights and Market Data - Raise a Query
About RationalStat LLC
RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client’s needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.
Contact
RationalStat LLC
Kimberly Shaw,
Content and Press Manager
US Phone: +1 302 803 5429
UK Phone: +44 203-287-1245
LinkedIn | Facebook | Twitter | Instagram | Pinterest
